Ashida Takashi
Division of Hematology and Rheumatology, Department of Internal Medicine, Kinki University Faculty of Medicine.
Rinsho Ketsueki. 2018;59(10):2343-2348. doi: 10.11406/rinketsu.59.2343.
"Guidelines for the use of red blood cell products, platelet transfusion concentrates and fresh frozen plasma based on scientific evidence" was published by the Japan Society of Transfusion Medicine and Cell Therapy. Each transfused blood product carries a certain risk of an acute or late adverse event. Hematologists must be familiar with transfusion-associated adverse events, such as transfusion-related acute lung injury, transfusion-associated circulatory overload, post-transfusion graft-versus-host disease, transfusion-transmitted viral infection, etc. Thus, these guidelines should be followed for the appropriate use of blood products according to trigger values and indications for transfusion.
日本输血医学与细胞治疗学会发布了《基于科学证据的红细胞制品、血小板浓缩物及新鲜冰冻血浆使用指南》。每一种输注的血液制品都有发生急性或迟发性不良事件的一定风险。血液学家必须熟悉输血相关不良事件，如输血相关急性肺损伤、输血相关循环超负荷、输血后移植物抗宿主病、输血传播病毒感染等。因此，应遵循这些指南，根据触发值和输血指征合理使用血液制品。
